Highlights Sera Prognostics, Inc.

Equities

SERA

US81749D1072

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
11.15 ^USD	+3.72%		+14.12%	+86.45%

Mar. 28	Sera Prognostics Insider Sold Shares Worth $727,853, According to a Recent SEC Filing	MT
Mar. 27	Sera Prognostics Insider Sold Shares Worth $364,484, According to a Recent SEC Filing	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (SERA) SERA PROGNOSTICS Posts Q4 Revenue $41,000	Mar. 20	MT
Sera Prognostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Sera Prognostics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 20	CI
Sera Prognostics Inc. Announces Preliminary Efficacy Met in Pivotal Prime Study Interim Look - Enrollment to Stop Due to Success	Dec. 06	CI
Earnings Flash (SERA) SERA PROGNOSTICS Posts Q3 Revenue $42,000	Nov. 08	MT
Sera Prognostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Earnings Flash (SERA) SERA PROGNOSTICS Reports Q2 Revenue $123,000	23-08-09	MT
Sera Prognostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Earnings Flash (SERA) SERA PROGNOSTICS Reports Q1 Revenue $100,000	23-05-10	MT
Sera Prognostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Earnings Flash (SERA) SERA PROGNOSTICS Reports Q4 Revenue $65,000	23-03-22	MT
SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-22	AQ
Sera Prognostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
Sera Prognostics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-22	CI
Sera Prognostics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-22	CI
Sera Prognostics, Inc. Announces Positive Top-Line Data from AVERT PRETERM TRIAL	23-02-15	CI
Sera Prognostics, Inc. Announces Publication of Data Predicting Clinical Utility and Cost Effectiveness of the Pretrm® Test-And-Treat Strategy Across Diverse Populations	22-11-15	CI
SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-09	AQ
Sera Prognostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Earnings Flash (SERA) SERA PROGNOSTICS Posts Q3 Revenue $87,000	22-11-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sera Prognostics, Inc.

Equities

SERA

US81749D1072

Highlights

Filters